General Announcement::Outcome of the Board Meeting to consider repurchase of Foreign Currency Debt

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
28-Sep-2018 12:39:45
Status
New
Announcement Sub Title
Outcome of the Board Meeting to consider repurchase of Foreign Currency Debt
Announcement Reference
SG180928OTHRACPE
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary Compliance Officer
Effective Date and Time of the event
28/09/2018 10:00:00
Description (Please provide a detailed description of the event in the box below)
Outcome of the Board Meeting under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to consider repurchase of Foreign Currency Debt

Attachments

BM_28 September 2018_SGX.pdf
Total size =3176K